Chambal Fertilisers and Chemicals (CHAMBLFERT) Q2 24/25 earnings summary

Executive summary

• Achieved standalone EBITDA of INR 834 crores in Q2, up 20% year-over-year; PAT at INR 500 crores, up 34% year-over-year.

• Consolidated PAT for Q2 was INR 536 crores, up 41% year-over-year; H1 consolidated PAT at INR 965 crores, up 37% year-over-year.

• Strong growth in Crop Protection Chemicals and Speciality Nutrients, with 36% y-o-y contribution growth and 214% revenue growth in new territories.

• Urea segment saw ~3% improvement in energy efficiency and a 125 MT/day production increase y-o-y.

• Interim dividend of Rs. 5 per equity share declared, payable by December 5, 2024.

Financial highlights

• Standalone revenue for Q2 FY25: Rs. 4,346.18 crore; H1: Rs. 9,279.41 crore.

• Standalone EBITDA: INR 834 crores in Q2 (up 20% YOY); PAT: INR 500 crores (up 34% YOY).

• Consolidated PAT: INR 536 crores in Q2 (up 41% YOY); H1: INR 965 crores (up 37% YOY).

• CPC & SN Q2 revenue: INR 289 crores (up 18% YOY); contribution: INR 83 crores (up 36% YOY).

• Earnings per share (consolidated, Q2 FY25): Rs. 13.39; H1: Rs. 24.58.

Outlook and guidance

• Focus on sustainable technologies, including biologicals and water-soluble fertilizers.

• Plans to enter hybrid and research variety seeds, with sales expected from Q25 onwards.

• Technical Ammonium Nitrate project on track, 37% complete, expected completion by October 2025.

• Launching 2-3 new biological products in the next financial year, especially for fungicides and nematicides.

• Interim dividend signals confidence in ongoing cash generation and profitability.